Acoustic neuroma affects nearly 18 to 28 people out of every 1 million every year. It is a rare non-cancerous tumor that develops on the vestibular nerve connecting the inner ear and brain. Symptoms include hearing loss, ringing in the ears (tinnitus), loss of balance, and facial numbness. Surgery is one of the common treatments to remove acoustic neuroma. The increasing cases of acoustic neuroma, rising healthcare spending, and growing geriatric population are some of the prime factors driving the growth of the acoustic neuroma market.

The acoustic neuroma market is estimated to be valued at USD 2.29 Bn in 2024 and is expected to reach USD 4.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9% from 2024 to 2031.

The current geopolitical situation is impacting the growth of the Acoustic Neuroma Market. Due to rising political tensions and security issues worldwide, cross-border collaborations and partnerships between organisations in different countries have reduced. This ishindering the exchange of knowledge and innovations in the field ofmedical research related to acoustic neuroma treatment.

Get More Insights On- Acoustic Neuroma Market

Get This Report in Japanese Language: 聴神経腫瘍市場

Get This Report in Korean Language: 음향신경종 시장